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Abstract
The transmissible spongiform encephalopathies (TSEs) or prion diseases are a group of
fatal neurodegenerative disorders characterised by the accumulation of a pathological form
of a host protein known as prion protein (PrP). The validation of abnormal PrP detection
techniques is fundamental to allow the use of high-throughput laboratory based tests, avoid-
ing the limitations of bioassays. We used scrapie, a prototype TSE, to examine the relation-
ship between infectivity and laboratory based diagnostic tools. The data may help to
optimise strategies to prevent exposure of humans to small ruminant TSE material via the
food chain. Abnormal PrP distribution/accumulation was assessed by immunohistochemis-
try (IHC), Western blot (WB) and ELISA in samples from four animals. In addition, infectivity
was detected using a sensitive bank vole bioassay with selected samples from two of the
four sheep and protein misfolding cyclic amplification using bank vole brain as substrate
(vPMCA) was also carried out in selected samples from one animal. Lymph nodes, oculo-
motor muscles, sciatic nerve and kidney were positive by IHC, WB and ELISA, although at
levels 100–1000 fold lower than the brain, and contained detectable infectivity by bioassay.
Tissues not infectious by bioassay were also negative by all laboratory tests including
PMCA. Although discrepancies were observed in tissues with very low levels of abnormal
PrP, there was an overall good correlation between IHC, WB, ELISA and bioassay results.
Most importantly, there was a good correlation between the detection of abnormal PrP in
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tissues using laboratory tests and the levels of infectivity even when the titre was low.
These findings provide useful information for risk modellers and represent a first step toward
the validation of laboratory tests used to quantify prion infectivity, which would greatly aid
TSE risk assessment policies.
Introduction
Scrapie is a member of the transmissible spongiform encephalopathy (TSE) family of diseases,
or prion diseases which naturally affects sheep, goats and mouflons [1]. Scrapie is transmissible
experimentally to several species, including ruminants and rodents, but there is no evidence of
transmission to transgenic mice expressing human prion protein (PrP) [2], and there is no epi-
demiological evidence to suggest that scrapie could pose a risk to public health. However, there
is the possibility that the bovine spongiform encephalopathy (BSE) agent, of proven zoonotic
potential, may have entered goat herds in the UK [3] and France [4] and possibly also sheep
flocks. It is therefore important to be able to detect any ovine TSE infectivity in tissues that
might enter the human food chain and in those that might lead to excretion of the infectious
agents onto sheep grazed pastures.
TSEs including scrapie are characterised by the accumulation of a pathological form of a
host encoded sialoglycoprotein known as prion protein (PrP). Since the link between the nor-
mal cellular prion protein (PrPc) and TSEs was established [5], several operational terms have
been used for the pathological form (abnormal PrP), including PrP scrapie (PrPSc), protease-
resistant PrP (PrPres), mainly used for Western blot (WB) results and disease-associated prion
protein (PrPd) used for immunohistochemistry (IHC). There are important differences be-
tween animal species in the distribution of the pathological prion protein isoform in TSEs; in
field cases of BSE in cattle it is restricted to the central and enteric nervous systems (CNS and
ENS, respectively), whereas in both natural scrapie and experimental sheep BSE abnormal PrP
is also found in the lymphoreticular system (LRS) and the peripheral nervous system (PNS)
[6].
In order to minimise the risk of TSE agents entering the human food chain specified risk
material (SRM) is removed from the carcasses of ruminants at slaughter and destroyed [7].
Whilst this approach minimizes the risk based on current knowledge, precise understanding of
the distribution of infectivity in several tissues and organs of TSE infected small ruminants
is incomplete.
Infectivity loads in tissues from scrapie affected sheep is still partially based on empirical
data generated from experimental titrations carried out and published in the early 1980s [8],
prior to the discovery of the role played by the PrP gene (Prnp) in TSEs [7]. More recent studies
on infectivity and detection of abnormal PrP have been carried out in sheep of different Prnp
genotypes [9–11], yet crucial information on several tissues from highly susceptible sheep of
the ARQ/ARQ genotype (where A, R and Q stand for alanine, arginine and glutamine at co-
dons 136, 154 and 171, respectively) is still lacking [7]. Quantification of infectivity in tissues
from natural scrapie cases in sheep of this genotype has been hampered because some of those
isolates do not readily transmit to mice. Therefore, data regarding the distribution of infectivity
in tissues of ARQ/ARQ sheep is mostly extrapolated from the results of laboratory tests for ab-
normal PrP. However, whereas the latter is believed to be the most useful marker of TSE dis-
ease identified to date, it has also been shown that its presence does not always directly
correlate with infectious titres [12] and bioassay is still required for verification.
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Recently, the bank vole (Myodes glareolus) has been shown to be highly sensitive to some
sources of natural scrapie that do not readily transmit to mice [13]. In the present study, the
vole bioassay was used to determine the distribution of scrapie infectivity in ARQ/ARQ Suffolk
sheep from a naturally affected intensely studied flock [14]. The distribution of infectivity was
then compared with the results of laboratory tests for abnormal PrP including IHC, WB and
enzyme-linked immunosorbent assay (ELISA), as the most commonly used in TSE diagnostics.
Furthermore, protein misfolding cyclic amplification (PMCA), a method for abnormal PrP de-
tection based on the in vitro conversion of PrPc, was applied to selected samples; this test is be-
coming increasingly used because of its sensitivity [15].
In summary, the aim of the study was to compare the distribution of infectivity and disease
associated prion protein in tissues of scrapie-affected sheep, with specific emphasis on those
with potential to enter the food chain; in so doing, we have tried to ascertain the predictive
value of in vitro laboratory test results in determining infectivity.
Materials and Methods
Sheep samples
Four 22–28 month old Suffolk sheep of the ARQ/ARQ scrapie susceptible Prnp genotype, clini-
cally affected with natural scrapie (animal numbers: B1216, B1217, B1221, B1223) from a well
studied and documented flock [14,16] and 4 age-matched, ARQ/ARQ, New Zealand derived,
scrapie free sheep (animal numbers: N523, N449, N456, N506) were culled by electrical stun-
ning followed by exsanguinations. At post-mortem a wide range of tissues was collected, in-
cluding: brain, trigeminal, stellate and thoracic sympathetic chain ganglia, sciatic and vagal
nerve trunks, 3rd eyelid, recto-anal mucosal associated lymphoid tissue (RAMALT), distal jeju-
nal lymph node (LN), prescapular LN, semitendinosus, oculomotor (ventral oblique and rectus
dorsalis) and tibialis cranialis muscles, liver, adrenal gland, tongue, ileum (including Peyer’s
patches and ENS), heart, lung, kidney and pancreas.
All animal procedures complied with the Animals (Scientific Procedures) Act 1986 and
were approved by the Moredun Research Institute ethics committee.
Each tissue sample was bisected and one piece immersed in 10% buffered formalin for
histopathological and IHC examinations and a second piece processed under sterile condition
to a homogenous tissue macerate to maximise homogeneity of abnormal PrP/infectivity in the
sample for each subsequent assay. Each tissue macerate was then divided into four separate
sterile tubes for future analyses (WB, ELISA, PMCA and bioassay) and stored at −80°C until
required.
Histology and Immunohistochemistry
All tissues from all sheep were processed by routine procedures and embedded in paraffin wax,
sectioned (5μm), mounted on glass microscope slides and stained with haematoxylin and eosin
or subjected to IHC labelling for abnormal PrP using primary antibody R145 as described pre-
viously [17].
Brain tissue was examined for the presence of vacuolation and the magnitude and distribu-
tion of abnormal PrP was scored in all tissues. The abundance of abnormal PrP in each visceral
tissue was subjectively scored from 0–3 where 0 corresponded to no labelling detected and 1, 2
and 3 corresponded to mild, moderate and severe accumulations of abnormal PrP, respectively.
As muscle samples showed abnormal PrP labelling in muscle spindles only and not in myo-
cytes, a semi-quantitative scoring system was applied where scores of 0, 1, 2, 3 corresponded to
0, 1, 1–5,>5 positively labelled muscle spindles, respectively.
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Western blot
Tissue samples (Table 1) from four scrapie-infected and one uninfected control sheep were
tested for abnormal PrP by Western blotting.
Approximately 200mg of each tissue examined was weighed into a ribolyser tube and 4 vol-
umes of 0.1M Tris pH8.0/0.1M NaCl buffer added. Tissues were disrupted at 6.5m/s x 40 sec
for two cycles using the Fast Prep machine (FP120, Bio101 Thermo Electron Corporation). Tis-
sue homogenates were used in the comparison of three sample preparation methods as follows:
Centrifugal concentration. 300μl of each tissue homogenate were shaken at 37°C with 2%
sarkosyl solution prior to treatment with proteinase K solution (50μg/ml) for 1h at 37°C with
shaking (1200rpm, Eppendorf Thermomixer). Digestion was terminated by adding Pefabloc
(SC Roche) to a final concentration of 1mM. Samples were then centrifuged at 20,000×g for 1h
at 10°C and pellets resuspended in 50μl 2x Sample Buffer (Invitrogen) and heated at 100°C/
5min prior to SDS-PAGE. A dilution series of 50%, 25% and 12.5% was made from the resus-
pended brain sample of each scrapie-infected sheep and included on each gel to act as a positive
control and to provide a range of intensities (standard curve) to which the other tissue signals
could be compared.
NaPTA precipitation. Tissue homogenate (0.5ml) was made up to 1ml with 4% sarkosyl
in Dulbecco’s PBS and shaken at 37°C for 10min. Benzonase (50U/ml final concentration) and
MgCl2 (1mM final concentration) were added prior to shaking at 50°C for 30min. Proteinase K
(PK) was added to a final concentration of 50μg/ml and incubated at 50°C for 60min prior to
addition of Pefabloc (1mM final concentration) to terminate digestion. Pre-warmed (37°C)
NaPTA solution was added to a final concentration of 0.4% and shaken at 37°C for a further
30 min. Samples were then centrifuged at 20,000g for 30min at 10°C and the resulting pellets
washed in 0.1% sarkosyl/PBS and 250mM Edetic Acid and re-pelleted at 20,000g /15min at
10°C. Final pellets were resuspended in 50μl 2xSB (Invitrogen) and heated at 100°C/5min prior
to SDS-PAGE. A dilution series of 50%, 25% and 12.5% was made from the resuspended brain
sample as before.
SDS-PAGE andWestern blotting. Only one animal’s set of tissues were analysed on each
gel to allow direct comparison of intensity between tissues. 10μl of sample was loaded onto
12% Bis-Tris NuPAGE gels (Invitrogen) run at 150V for 1h. Proteins were electrotransferred
Table 1. Proportion of sheep testing PrPSc positive in each tissue by threeWestern blot methods.
BioRad Centrifuge NaPTA
no. positive/ no. tested no. positive/ no. tested no. positive/ no. tested
Brain 4/4 4/4 4/4
Dist. Jej LN 4/4 (49) 4/4 (23) 4/4 (30)
Prescap. LN 4/4 (44) 4/4 (19) 4/4 (18)
Oculo. ms 3/4 (5) 3/4 (7) 2/4 (3)
Sciatic 1/4 (15) 3/4 (12) 1/4 (7)
Kidney 2/4 (12) 1/4 (9) 1/4 (5)
Tongue neg neg neg
Heart neg neg neg
Liver neg neg neg
Pancreas neg neg neg
Semitend. ms neg neg neg
Cran. tib. ms neg neg neg
Number in parentheses is the mean relative intensity (%) compared with 1/8 diluted brain sample.
doi:10.1371/journal.pone.0122785.t001
Infectivity and PrP in Nervous and Edible Tissues from Scrapie Sheep
PLOSONE | DOI:10.1371/journal.pone.0122785 March 25, 2015 4 / 21
onto PVDF membrane at 30V for 1h, then subsequently placed in 5% non-fat milk/Tris Buff-
ered Saline Tween 20 (TBST) to block non-specific binding prior to being probed with anti-
body P4 (R-biopharm, 1:2000 dilution in TBST). Secondary antibody (ECL Mouse IgG, HRP-
linked F(ab')₂ fragment from sheep, Amersham) was applied at 1:20,000 dilution in TBST for
1h. Immunoreactivity was detected using Pierce WestFempto chemiluminescent reagents and
a Kodak IS440 image station.
BioRad TeSeEWestern blot. All tissue samples were tested using the BioRad TeSeE WB
Sheep and Goat kit according to the manufacturer’s instructions. The only variable introduced
was the resuspension of some lymph node samples with large final pellets into two volumes of
sample buffer prior to loading. A dilution series of 50%, 25% and 12.5% was made from the re-
suspended brain sample as before.
Image analysis. Western blot images were captured using Kodak 1D 3.6 software. Band
analysis was carried out and the mean intensity of abnormal PrP bands was measured. To
allow for gel to gel variation, only samples from the same gel were compared and quantitatively
analysed. The mean intensities of the edible tissue samples were compared with the mean in-
tensity value of the 12.5% dilution brain sample on the same gel as this sample gave consistent
intensity values without signal saturation, which occurred at higher concentrations.
ELISA
The Bio-Rad TeSeE BSE diagnostic test was used as directed by the manufacturers with modifi-
cations to take into account the different consistencies of the tissues and levels of PrPc in the
uninfected tissues. Tissues were ribolysed, using a single large (6mm diameter) ceramic bead,
to give 20% (w/v) homogenate. Samples were treated with DNAse following ribolysation. Fol-
lowing precipitation and centrifugation at 15,000g for 7min, the resultant pellets were solubi-
lised by incubating in Reagent C at 100°C for 5min. Thereafter the method was followed
exactly as per the manufacturer’s instructions. Absorbance was read at 450nm and 620nm
using a Victor multi-well plate reader (Perkin-Elmer).
To determine the lowest concentration of PK for each tissue where PrPc was undetectable
by the assay, samples from three unexposed control sheep were treated with decreasing con-
centrations of PK. To determine the relative concentrations of PrPc in each tissue we also as-
sayed for PrP content in the absence of PK. The relative amounts of undigested PrP observed
correlated with those published by Moudjou et al. (2001) and the range of PK concentrations
required to digest all PrPc was from 0.086 units/ml (prescapular LN) to 1.72 units/ml (tongue,
kidney and semitendinosus muscle). When spiked with scrapie positive brainstem and digested
using the pre-determined concentration of PK, each matrix (n = 2) gave absorbance readings
above the designated assay cut-off point and the matrix did not significantly interfere with the
detection of abnormal PrP.
For the determination of abnormal PrP in the absence of PK, the “IDEXX Herd-Chek BSE/
Scrapie Antigen EIA Test” was carried out according to the manufacturer’s instructions with
some modifications. In brief, the samples were homogenised as described but with the incorpo-
ration of a single large (6mm diameter) ceramic bead and by performing three agitation cycles
at 6.5ms-1 each for 45 seconds; the homogenates were cooled between each cycle. This facilitat-
ed better homogenisation of tissues. The samples were mixed with the working plate diluents,
loaded on to the antigen-capture plate and shaken for 150min at room temperature. Abnormal
PrP was detected using the kit-conjugated anti-PrP antibodies, visualised with TMB and absor-
bance read at 450nm and 620nm. For end-point dilution the samples were serially diluted in
normal brain homogenate prior to PK digestion.
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Threshold values for each individual tissue were also calculated. Eight tissues (excluding
brain) from ARQ/ARQ negative control sheep (n = 15), from the AHVLA TSE-free flock, were
assayed using both modified protocols and the mean absorbance calculated. This mean absor-
bance value +3 standard deviations was used as the cut-off values above which the sample was
considered to be positive.
Bioassay in bank voles
Brain, sciatic nerve, prescapular lymph node, kidney, oculomotor and semitendinosus muscle,
heart and tongue from B1223 and B1213 were used for this part of the study having showed
the larger number of positive samples by IHC. All samples were homogenised to 10% w/v
(10−1 dilution) in phosphate buffered saline (PBS). For the brain inocula, serial tenfold dilu-
tions in PBS (10−1–10−6) were prepared and used for end point titration into voles.
Groups of 15–20 eight-weeks-old bank voles (Myodes glareolus) were injected by the intra-
cerebral route with 20μl of 10% homogenates of edible tissues or serial dilutions of brain inoc-
ula into the left cerebral hemisphere under ketamine (0.1 μg/g) anaesthesia. Bank voles have a
polymorphism at codon 109 of the PrP gene, coding for either methionine or isoleucine, and
this amino acid variation influences the susceptibility of voles to different prion strains [18,19].
All voles used in this study were homozygous for methionine at codon 109 as they are very sen-
sitive to the source of scrapie used here [13]. Beginning 1 month after inoculation, animals
were examined twice per week until the appearance of neurological signs from which point
they were examined daily. Diseased animals were culled (using a rising concentration of carbon
dioxide) at the terminal stage of disease but before neurological impairment was such that it
compromised welfare and, especially, adequate drinking and feeding. Survival time (days post-
infection, dpi) was calculated as the interval between inoculation and culling. ID50 per gram
were determined by end point titration according to the Spearman and Kärber method [20].
All the bioassays in bank voles were concluded between 735 and 868 dpi, by culling all the
voles that were still alive at that time. Survivors were animals alive until the end of the experi-
ment with no signs of infection. Animals culled for intercurrent disease at<200 dpi were all
negative by WB and were excluded from analysis. The attack rate was calculated as the ratio of
voles confirmed positive over the number of voles inoculated, excluding animals culled for in-
tercurrent disease before 200 dpi.
The brains of voles culled at the terminal stage of disease, for intercurrent disease or at the
end of the experiments, were collected. Each brain was cut parasagitally into two parts, the
smaller one stored at −80°C for biochemical studies, the other fixed in 10% buffered formalin
for histological assessment of TSE-specific spongiform degeneration analysis as described pre-
viously [21]. PK-resistant PrP was examined by Western blotting in SDS-PAGE gels, as previ-
ously described [21].
All the procedures used in this study have been approved by the Service for Biotechnology
and Animal Welfare of the Istituto Superiore di Sanità and authorized by the Italian Ministry
of Health, according to Legislative Decree 116/92, which implemented the European Directive
86/609/EEC on laboratory animal protection in Italy. Bank voles (Istituto Superiore di Sanità
breeding colony) were housed in standard cages and treated according to Legislative Decree
116/92 guidelines, and animal welfare was routinely checked by veterinarians from the Service
for Biotechnology and Animal welfare. All animals were individually identified by a passive
integrated transponder.
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Western blot analysis of the inocula
Abnormal PrP contained in the inocula used to infect voles was detected by WB using a meth-
od published previously, which showed high sensitivity for abnormal PrP detection in periph-
eral tissues [22]. For WB analysis of the inocula, 1 ml of tissue homogenates (10% w/v in PBS
pH 7.4) were added to 110l of PBS containing 20% Sarcosyl (Sigma) to obtain a final Sarcosyl
concentration of 2% and incubated for 20min at 37°C with gentle shaking before PK (50g/ml)
digestion for 60min at 37°C with gentle shaking. Protease treatment was stopped with phenyl-
methylsulfonyl fluoride (PMSF, Sigma) (33μl of a stock solution, to give a final concentration
of 3mM) and the treated homogenates were centrifuged at 20,000g for 60min at 20°C. Pellets
were dissolved in 40μl of NU-PAGE sample buffer (Invitrogen), heated at 95°C for 10min and
centrifuged in a microcentrifuge for 5min at 8,000g. Twenty microlitres of the resultant super-
natants (50mg tissue equivalent per lane) were loaded onto 12% bis-Tris polyacrylamide gels
(Invitrogen). Electrophoresis was carried out at 200V for 40min andWB performed on PVDF
membranes (Millipore). The blots were blocked for non-specific binding in PBS containing
0.1% Tween20 and 3% non-fat milk powder for 1h. Abnormal PrP was detected with the mono-
clonal antibody P4 (0.4μg/ml, R-Biopharm) for 60min at room temperature. Peroxidase-conju-
gated goat anti-mouse IgG (1:80,000 for 1h, Pierce) was used as secondary antibody. The
membranes were developed with the SuperSignal West Femto enhanced chemiluminescence
method (Pierce). Chemiluminescence was detected with the VersaDoc imaging system (Bio-
Rad).
The experiment was repeated 3 times and in all experimental sessions the respective brain
dilutions were analysed in comparison with the edible tissues.
PMCA
Brain, sciatic nerve, tongue, prescapular lymph node, heart, kidney, semitendinous and oculo-
motor muscels from sheep B1216 were examined in this part of the study. For the preparation
of substrates, voles carrying M109M PrP genotype [19] were culled using carbon dioxide and
immediately perfused with phosphate-buffered saline (PBS) containing 5mM ethylendiamine-
tetraacetic acid (EDTA). Immediately after perfusion, the brains were removed from the skull
and frozen at −80°C. Brain homogenates (10% w/v) were prepared in conversion buffer (PBS,
pH 7.4; 0.15M NaCl; 1% Triton X-100) with the Roche Complete Protease inhibitor cocktail (1
tablet in 50ml conversion buffer), using new and dedicated glass potters. Substrates were divid-
ed into aliquots and either used or stored at −80°C immediately after homogenisation. Prepara-
tion and storage of substrates were carried out in a laboratory never previously used for prion
research, using equipment specifically dedicated and maintaining in rigorously prion-free con-
ditions. An homogeneous pool of substrates was prepared by mixing 5 individual substrates
from 2–4 months old bank voles.
Serial automated PMCA (saPMCA) conditions and the additional procedures to minimise
contamination have been described previously [23]. Briefly, 20μl of each inoculum was added
to 180μl of substrate and mixed; 60μl of the reaction mixture was transferred into a 0.5ml
screw cap PMCA tube (Multiply—Safecup, Sarstedt) for the first round of amplification. Tubes
containing the reaction mixtures were incubated at 37°C, placed in a disk-shaped rack on the
microplate horn of the sonicator (Misonix S3000) and the horn placed in a gravity oven. Water
in the horn was circulated in a thermal bath at a constant temperature of 37°C. The standard
sonication programme consisted of 20s sonication pulses every 30min for 48h periods. At the
end of each round, the PMCA material was gently mixed and diluted 1:10 in fresh substrate
ready for a further amplification step. All the inocula were amplified for 9 consecutive rounds.
Manipulation of the samples and passages were carried out in a laminar flow hood, using
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double filter pipette tips. For the WB analysis of PMCA products, 20μl of PMCAmaterial was
digested with 100μg/ml PK (Sigma-Aldrich). Samples were shaken at 900 revolutions per min-
ute (rpm) for one hour at 37°C. Digestion was subsequently blocked by adding 2μl of 10mM
phenylmethylsulfonyl fluoride (PMSF) (Pierce Biotechnology—Thermo Fisher Scientific) to
samples which were then incubated for 5min at 4°C. Ten micro-litres of NuPAGE LDS Sample
Buffer (4X) and 3μl NuPAGE Sample Reducing Agent (10X) were added to each tube and sam-
ples were denatured by incubation at 90°C for 10 min Subsequently, 12μl of PK-digested
PMCA samples were resolved by SDS-PAGE on 12% bis-Tris polyacrylamide gels (Invitrogen)
and transferred to PVDF. Non-specific binding on the membrane was blocked with 1% pow-
dered skim milk in PBS for one hour at room temperature and incubated with mouse anti-PrP
monoclonal antibody SAF84 (Cayman Chemical). After washing, the membrane was incubated
for 1h at room temperature with secondary HRP-conjugated antibody (diluted 1:30,000,
ImmunoPure Peroxidase Conjugated Goat Anti-Mouse IgG (H+L) Pierce Biotechnology—
Thermo Fisher Scientific) and signals were detected using SuperSignal West Femto Maximum
Sensitivity Substrate (Pierce Biotechnology—Thermo Fisher Scientific).
Results
Histology and Immunohistochemistry
All four scrapie-affected sheep examined showed severe and widespread vacuolation in the
CNS and abnormal PrP was detected by IHC throughout the brain, peripheral nervous system
and lymphoid tissues. Abnormal PrP was consistently detected in the adrenal glands and in-
consistently detected in the kidneys and striated muscle samples (Fig. 1) but not detected in the
other viscera examined.
The pattern or profile of abnormal PrP accumulation in each sheep was typical of that previ-
ously observed in ARQ/ARQ scrapie-affected Suffolk sheep in this flock [24]. The levels of vac-
uolation and the magnitude of the abnormal PrP profile were similar in each of the 4 sheep
studied and did not assist in selection of tissues for transmission studies. Accordingly, subjec-
tively determined levels of abnormal PrP accumulation in viscera, which were more variable
than in CNS, were used to select the two sheep for transmission to bank voles.
In common with previous studies of scrapie-affected sheep in this flock [16] abnormal PrP
accumulation was found in all the lymphoid tissues examined and was almost exclusively re-
stricted to secondary follicles, more than 80% of which were positive. The only exception was
the 3rd eyelid, where only one sample was found to contain abnormal PrP. Lymphoid tissues of
the gut showed the highest proportion of positive secondary follicles. All sheep were positive
for abnormal PrP in the RAMALT which can be used for ante-mortem diagnosis of clinical
and pre-clinical scrapie [25,26].
In each of the scrapie affected sheep, abnormal PrP was detected in neurons and satellite
cells of all ganglia examined including those of the ENS. Abnormal PrP was also present at
lower levels in the vagal and sciatic nerve trunks, where it localized within myelinated process-
es. In contrast to an earlier report, abnormal PrP was not detected in nerve endings of the ton-
gue, or in sensory taste receptors [27] but, as previously described for this Suffolk flock, it was
consistently present in the adrenal medulla [28]; here, it was mainly associated with the plas-
ma-membranes of chromaffin cells, which are derived from the neural crest and are a modified
post-ganglionic neuronal cell population, and to a lesser extent with peripheral nerve terminals
[29]. Thus, each scrapie-affected sheep showed widespread abnormal PrP accumulation within
both sympathetic and parasympathetic components of the peripheral nervous system and
modified neuronal cell populations.
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In each of the three striated muscles examined, abnormal PrP accumulation was confined to
muscle spindles and was not detected in myocytes. Abnormal PrP was detected in two muscle
spindles of the semitendinosus muscle of only one scrapie affected sheep. Muscles spindles
were more frequent in the cranialis tibialis muscle (a lower hind limb muscle) and abnormal
PrP positive spindles were found in two sheep. Numerous muscle spindles were present in the
ocular muscle samples, and in each case abnormal PrP accumulation was detected in each mus-
cle sample. Thus, in scrapie-affected Suffolk sheep of this flock abnormal PrP accumulation is a
common feature of muscle spindles and the frequency of abnormal PrP detection in an individ-
ual muscle tissue appears to be proportionate to the number of spindles present. Abnormal
PrP within muscle spindles was located in structures resembling small nerves and also within
intrafusal muscle cells. In contrast, there was no evidence of abnormal PrP accumulation in
motor end plates innervating myocytes.
Multiple samples of kidney were taken from each sheep and a minimum of three specifically
included representation of the renal pelvis. Only two of the four sheep showed abnormal PrP
Fig 1. Different levels of abnormal PrP immunolabelling in selected tissues from scrapie positive
sheep using R145 as primary antibody and Mayer’s haematoxylin as counterstain. A: Widespread
abnormal PrP labelling in the adrenal gland from B1216 (original magnification ×20). B: Abnormal PrP in the
secondary follicles of the prescapular lymph node from B1217 (original magnification ×10). C: Widespread
distribution of Abnormal PrP in the obex from B1217 (original magnification ×10). D: Very localised deposition
of Abnormal PrP in the spindles of the semitendinous muscle from B1216 (original magnification ×40). E and
F: examples of different level of deposition of PrPd in the renal papillae from respectively B1223 and B1217
(original magnification E ×20 and F×40).
doi:10.1371/journal.pone.0122785.g001
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accumulation in renal pelvis tissues and none showed accumulation in the cortex. This moder-
ate frequency of abnormal PrP accumulation in the renal pelvis is consistent with previous ob-
servations in this flock and in experimental scrapie infections [30,31].
Abnormal PrP was not detected in the liver, pancreas, myocardium or lung and all tissue
samples from the negative control sheep were also negative.
Detection of abnormal PrP by biochemical tests
Western blot. Abnormal PrP was consistently detected in the brain and in the prescapular
and distal jejunal LNs by all three WB methods (Fig. 2). All samples of tongue, liver, heart, pan-
creas and semitendinosus and tibialis cranialis muscles were abnormal PrP negative by all
three methods. Sciatic nerve, kidney and oculomotor muscle results varied between methods
(Table 1). For example, kidney was positive for abnormal PrP in two animals by BioRad TeSeE
WB but only in one using the centrifugal concentration method or NaPTA. Conversely, sciatic
nerves of three sheep were positive using centrifugal concentration but only one was detected
using the BioRad and NaPTA tests.
The relative WB signal intensity of each tissue was measured and expressed as a percentage
of a 1/8 dilution of brain sample from the same animal (Table 1). Using the mean of the four
scrapie-positive animals, all three WB methods ranked non-brain tissues in the same order,
with distal jejunal LN giving the strongest signal followed by prescapular LN, sciatic nerve and
kidney, with oculomotor muscle showing the lowest signal intensity.
ELISA. Using the BioRad TeSeE sheep and goat ELISA abnormal PrP was detected in the
brain (4/4), oculomotor muscles (3/4), prescapular LN (4/4) and kidney (4/4) from the four in-
fected sheep (Table 2). All other tissues tested were negative by this method. In some cases the
signals were very low and only just above the experimentally determined cut-off point. For ex-
ample the signals from the kidney and the oculomotor muscle were below 0.1 except for the
left kidney from sheep 1216B. These values would fall well below the manufacturer’s cut-
off value.
Using the Idexx Herd-Chek scrapie antigen assay abnormal PrP was detected in brain (4/4),
oculomotor muscle (3/4), prescapular LN (4/4), kidney (1/4) and sciatic nerve (3/4) of the af-
fected sheep (Table 2). All other tissues were negative. Largely the results of the two ELISA as-
says were comparable for brain, prescapular lymph node, heart, liver and semitendinosus
muscle. However, the Idexx assay was able to detect abnormal PrP in sciatic nerve for which
the Bio-Rad assay gave values below the cut-off value.
As described for the Western blot results we also estimated the relative levels of abnormal
PrP in the positive tissues by end-point dilution using the IDEXX Herd-Chek EIA (Table 3). In
all cases the brain contained the highest levels of PrPSc. The prescapular lymph nodes con-
tained on average 1.1 logs less than brain, the highest concentration of PrPSc outside the CNS.
The oculomotor muscle and the sciatic nerve (where it could be measured) contained between
2.1 and 3.3 logs less respectively than the brain. Levels of PrPSc could only be measured in one
kidney of one sheep with similar levels as the oculomotor muscle and sciatic nerve (in the other
sheep it was undetectable by this method). This comparison in quantity can only be an estimate
of relative levels of abnormal prion protein since the assays have no standard curve from which
to assess the levels quantitatively.
Bioassay in bank voles. In both sheep analysed by bioassay the prescapular lymph nodes
(LNs), sciatic nerves, oculomotor muscles and kidneys contained detectable levels of infectivity
by bank vole bioassay (Table 4). In contrast, bank voles inoculated with heart, tongue or semi-
tendinosus muscle from either sheep did not show clinical signs of prion disease and no
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abnormal PrP was found upon post-mortem processing and analyses of tissues by histopathol-
ogy andWestern blot (Table 4).
We determined the prion titre in the brains of the two sheep by end-point titration (Table 5
and S1 Fig.). The infectivity titres, calculated by the method of Spearmann and Karber [20]
were 105.01 i.c. ID50 U/g for the brain of sheep 1216B and 10
5.35 i.c. ID50 U/g for the brain of
sheep 1223B. Given that none of the tissues other than the brain induced 100% attack rate in
voles (Table 5), their prion titre could not be derived from incubation time assay and so was es-
timated by direct comparison with brain titration experiments (Table 5 and S2 Fig.). By this
Fig 2. Relative intensity of chemiluminescent signal of PrPSc in tissues from 4 ARQ/ARQ sheepmeasured fromWestern blot image data (see
adjacent panel) of edible tissues compared with a 12.5% dilution of brain sample by three western blot methods. (a) BioRad TeSeEWestern Blot, (b)
centrifugal concentration, (c) NaPTA precipitation. Red diamonds indicate high signal; yellow – low signal; blue – negative.
doi:10.1371/journal.pone.0122785.g002
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estimation, the two sheep showed a similar magnitude of prion distribution in tissues other
than brain. The prescapular LNs contained the highest levels of infectivity, approximately 2
logs less than the brain or 103.01–103.35 i.c. ID50 U/g, while scrapie prions were barely detectable
in kidneys (>3 logs less than the brain). The titres in sciatic nerves and oculomotor muscles
were intermediate being 2–3 logs less than the brain.
Detection of abnormal PrP in the inocula used for bioassay. During the project it be-
came evident that there might have been differences between aliquots or sub-samples from the
same organ or tissue. In order to compare biochemical tests and bioassay results as accurately
as possible we analysed by WB all the tissue inocula prepared for the bioassay, including the
different brain dilutions. For each inoculum, 3ml were analysed in 3 independent WB experi-
ments (1ml for each WB assessment) and the results are summarised in Table 6.
Table 2. ELISA results.
Tissue Sheep Number
B1216 B1223 B1221 B1217 N523
BR Idexx BR Idexx BR Idexx BR Idexx BR Idexx
Brain 2.862 2.770 2.817 2.781 2.773 2.814 1.860 2.793 0.006 0.018
Prescap LN 1.670 0.822 1.770 2.816 1.403 2.598 2.630 1.892 0.004 0.045
Sciatic Nerve 0.009 0.333 0.007 0.538 0.011 0.049 0.008 0.438 0.002 0.041
Kidney (left) 0.223 0.044 0.048 1.420 0.045 0.050 0.020 0.047 0.016 0.030
Kidney (right) 0.095 0.048 0.028 0.131 nd 0.042 0.020 0.059 0.015 0.063
Oculomotor muscle 0.063 0.451 0.034 0.094 0.006 0.221 0.049 0.227 0.005 0.031
Tongue 0.025 0.041 0.021 0.044 0.018 0.045 0.137* 0.032 0.013 0.035
Heart (left ventricle) 0.007 0.061 0.014 0.049 0.021 0.042 0.013 0.039 0.008 0.038
Semitendinosus muscle (left) 0.022 0.054 0.015 0.058 0.027 0.050 0.014 0.053 0.015 0.044
Semitendinosus muscle (right) 0.024 0.050 0.015 0.060 nd 0.044 0.015 0.050 0.011 0.045
Detection of PrPSc in target tissues from four scrapie-infected ARQ/ARQ, MRI sourced, Suffolk sheep (B1216, B1223, B1221, B1217B) and an unexposed
ARQ/ARQ sheep (N523) using modiﬁed Bio-Rad TeSeE sheep and goat ELISA (BR) and the Idexx Herd-Chek scrapie antigen assay (Idexx). Values in
bold are greater than the experimental cut-off values for each tissue. Tissues from the sheep underlined were inoculated into bank voles to determine
infectivity. The numbers represent the absorbance values (450–620 nm). Each tissue was assayed at least twice and the results shown are values for
assays completed in parallel on the same day.
Nd represents not done.
* In a repeat assay the value for this tissue fell below the cut-off value.
doi:10.1371/journal.pone.0122785.t002
Table 3. Relative quantity of PrPSc in edible tissues asmeasured by end-point dilution using the Idexx HerdChek antigen assay.
Tissue Sheep Number
B1216 B1223 B1221 B1217
Brain 1/2048 1/1024 1/2048 1/1024
Prescap LN 1/64 1/512 1/32 1/128
Sciatic Nerve 1/8 1/8 nd 1/16
Kidney (left) nd 1/128 nd nd
Kidney (right) nd 1/2 nd nd
Oculomotor muscle undiluted nd 1/4 1/4
The values shown are the ﬁnal dilution where a positive signal was observed. Nd represents not done as these tissues were negative.
doi:10.1371/journal.pone.0122785.t003
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In both sheep chosen for bioassay, the last positive brain dilution was 10−3, which suggests
that the WB was a log10 less sensitive than the bank vole bioassay (Table 6). Among the visceral
tissues analysed, prescapular LNs showed the highest levels of PrPSc, showing PrPSc amounts
intermediate between brain dilutions 10−2 and 10−3. Clear-cut positive signals, corresponding
Table 4. Bioassay of edible tissues in voles.
Sheep
ID
Tissue Clinically + WB + N (surv.
t. range)








B1223 Sciatic Nerve 6 (218–554) 1 (487) 6 (280–600) 2 (835) 7/15
B1216 Sciatic Nerve 5 (236–697) 2 (309; 561) 6 (211–656) 7 (735) 7/20
B1223 Prescap. LN 11 (189–475) 2 (250–369) 4 (202–657) 0 13/17
B1216 Prescap. LN 8 (242–463) 2 (277; 281) 3 (298–551) 1 (805) 10/14
B1223 Kidney 1 (466) 0 10 (204–700) 6 (785) 1/17
B1216 Kidney 1 (652) 1 (670) 9 (461–767) 8 (789) 2/19
B1223 Oculomotor
Ms
6 (328–405) 0 6 (340–747) 3 (833) 6/15
B1216 Oculomotor
Ms
1 (204) 0 10 (228–788) 6 (830) 1/17
B1223 Semitend. Ms 0 0 12 (202–719) 4 (805) 0/16
B1216 Semitend. Ms 0 0 10 (369–699) 8 (789) 0/18
B1223 Heart 0 0 10 (375–771) 7 (805) 0/17
B1216 Heart 0 0 9 (391–645) 4 (805) 0/13
B1223 Tongue 0 0 6 (347–789) 5 (830) 0/11
B1216 Tongue 0 0 5 (211–571) 5 (831) 0/10
* Clinically healthy voles culled at the end of the experiment.
doi:10.1371/journal.pone.0122785.t004
Table 5. Attack rates and survival times in voles inoculated with edible tissues from scrapie affected sheep in comparison to brain endpoint
dilutions.
Sheep B1223 Sheep B1216
Attack rate (%) Survival time mean (SD) Attack rate (%) Survival time mean (SD)
Tissues
Brain−1 100% 187 (13) 100% 176 (13)
Brain−2 100% 225 (93) 100% 212 (39)
Brain−3 92% 351 (93) 73% 278 (46)
Brain−4 23% 403 (154) 8% 216
Brain−5 0% 0%
Brain−6 0% 0%
Sciatic Nerve 47% 339 (153) 35% 411 (168)
Tongue 0% 0%
Prescap. LN 76% 276 (80) 71% 317 (71)
Heart 0% 0%
Kidney 6% 456* 11% 652–670**
Semitend. Ms 0% 0%
Oculomotor Ms 40% 376 (28) 6% 204*
* the survival time of the only positive vole is reported
** the survival times of the two positive voles are reported
doi:10.1371/journal.pone.0122785.t005
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to a concentration less than brain dilution 10−3 were also observed in sciatic nerves of both
sheep and in the oculomotor muscles of sheep 1223B. The kidney of 1223B and the oculomotor
muscle of 1216B gave unambiguous PrPSc signals in 1 out of 3 WB experiments only, while all
other tissues were repeatedly negative. The comparison between the WB and bioassay results
suggest a good correlation between the amount of PrPSc present and the level of infectivity as
determined by bioassay (Table 6). Results of IHC, WB, ELISA and bioassay are summarised in
Table 7.
In vitro converting activity in the inocula used for bioassay. We have previously estab-
lished vPMCA as a very sensitive and reliable in vitro conversion assay [23]. For this part of the
study we used the inocula corresponding to the different brain dilutions and peripheral tissues
of sheep 1216B as seeds for vPMCA and performed 9 PMCA rounds, with WB analysis after
the 3rd, 5th, 7th and 9th rounds (Table 6 and Fig. 3). Brain dilutions up to 10−3 were already pos-
itive after the 3rd PMCA round, reaching 10−4 and 10−5 dilutions at the 5th and 7th rounds, re-
spectively; afterwards, no further converting activity was detected in higher brain dilutions up
to 9 PMCA rounds. Since the 10−5 brain dilution was negative by bioassay, this would imply a
*10 fold higher sensitivity of PMCA compared to bioassay (Table 6). In spite of this higher
sensitivity, vPMCA only detected converting activity in the same visceral tissues which con-
tained detectable levels of infectivity by bank vole bioassay, i.e. sciatic nerve, prescapular lymph
node, kidney and oculomotor muscles (Table 6 and Fig. 3). In these tissues, vPMCA-converted
abnormal PrP was detected after 5 (oculomotor muscles and prescapular lymphnode) or 7
Table 6. Comparison of PrPSc, infectivity and converting activity by PMCA in the inocula.
Sheep B1223 Sheep B1216
WB* Bioassay** WB* Bioassay** PMCA
Brain −1 pos pos pos pos pos
Brain −2 pos pos pos pos pos
Brain −3 pos pos pos pos pos
Brain −4 neg pos neg pos pos
Brain −5 neg neg neg neg pos
Brain −6 neg neg neg neg neg
Sciatic Nerve + ++ + ++ pos
Tongue − − − − neg
Prescap. LN ++ +++ ++ +++ pos
Heart − − − − neg
Kidney +/− + − + pos
Semitend. Ms − − − − neg
Oculomotor Ms + ++ +/− + pos
* For the brain dilutions, only positive and negative dilutions are indicated. For the edible tissues a semi-quantiﬁcation is provided. The WB signal was
semi-quantiﬁed as follows:
+++ = a tissue positive in all experiments and with a WB signal between brain dilutions −2 and −3
++ = a tissue positive in at least 2/3 experiments and with a WB signal similar to brain dilution −3 or less
+/− = a tissue positive in 1/3 experiments and with a WB signal below brain dilution −3
** For the brain dilutions, only positive and negative dilutions are indicated. For the edible tissues a semi-quantiﬁcation is provided. The bioassay results
were categorised as follows (see Table 5 and S2 Fig.)
+++ = similar to brain dilution −3 or more efﬁcient
++ = between brain dilutions −3 and −4
+ = similar to brain dilution −4 or less efﬁcient
doi:10.1371/journal.pone.0122785.t006
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(sciatic nerve and kidneys) vPMCA rounds, while tissues that were negative by bioassay (heart,
tongue and semitendinosus muscle) remained negative up to the 9th vPMCA round (Table 6
and Fig. 3). Eight unseeded vPMCA reactions run in parallel as negative controls remained
negative up to the 9th vPMCA round (S3 Fig.).
Discussion
We have studied the distribution of scrapie infectivity and Abnormal PrP in 4 ARQ/ARQ
sheep naturally affected with scrapie with a neuropathological phenotype indistinguishable
from other scrapie cases in sheep of the same genotype from different European countries [13];
these previous studies have reported the tissue distribution of PrPSc by IHC but have limited
biochemical and bioassay data [16,14,32]. We have found detectable levels of infectivity and/or
abnormal PrP in all 4 sheep in some of the edible tissues, such as skeletal muscles and kidneys,
or anatomical structures dispersed within them, such as lymph nodes, nerves and autonomic
ganglia. However, no evidence of infection was found in the heart, tongue, pancreas and liver
from any of the sheep. The detection of infectivity and abnormal PrP in kidneys corroborates
Table 7. Summary of the IHC, WB, ELISA and bioassay results.
Scrapie 1 (B1216) Scrapie 2 (B1223) Scrapie 3 (B1221) Scrapie 4 (B1217) Negative Control
(N523)
Tissues
IHC WB E VB IHC WB E VB IHC WB E VB IHC WB E VB IHC WB E VB
Brain ++
+
+/+/+ +/+ pos ++
+
+/+/+ +/+ pos ++
+
+/+/+ +/+ nd ++
+







+/+/+ nd nd ++
+
+/+/+ nd nd ++
+
+/+/+ nd nd ++
+

















+/+/+ +/+ nd ++
+





+/+/+ +/+ + ++
+






+/+/+ +/+ nd − − /−
/−
−/− nd
Sciatic nerve + −/+/− −/+ ++ + +/+/− −/+ ++ + −/−/nd −/− nd ++ −/+/+ −/+ nd − − /−
/−
−/− nd




+/+/+ +/+ + − +/−/− +/− nd ++ − /−
/−







−/− − − −/−
/−
−/− − − − /−
/−
−/− nd − − /−
/−









nd nd − − /−
/−
nd Nd − − /−
/−
nd nd ++ − /−
/−
nd nd − − /−
/−
nd nd
Tongue − − /−
/−
−/− − − − /−
/−
−/− − − − /−
/−
−/− nd − − /−
/−
+/− nd − − /−
/−
−/− nd
Heart − − /−
/−
−/− − − − /−
/−
−/− − − − /−
/−
−/− nd − − /−
/−
−/− nd − − /−
/−
−/− nd
Liver − − /−
/−
−/− nd − − /−
/−
−/− nd − − /−
/−
−/− nd − − /−
/−
−/− nd − − /−
/−
−/− nd
Pancreas − − /−
/−
nd nd − − /−
/−
nd nd − − /−
/−
nd nd − − /−
/−
nd nd − − /−
/−
nd nd
IHC: Score denotes the abundance of PrPd in each visceral tissue; no labelling (−), mild (+), moderate(++) or severe accumulation (+++) of PrPd. For
muscle samples a semi-quantitative scoring system was applied to no. of positively labelled spindles; 0 (−), 1 (+), 1–5 (++), >5 (+++)
WB: +1/ +2/ +3 denotes pos/neg results from three separate methods where 1 = BioRad; 2 = centrifugal concentration; 3 = NaPTA
E = ELISA: +1/ +2 denotes pos/neg results from two separate methods where 1 = BioRad; 2 = IDEXX
VB = Vole bioassay results were categorised as follows (+++) = similar to brain dilution-3 or more efﬁcient,
(++) = between brain dilutions −3 and −4, (+) = similar to brain dilution −4 or less efﬁcient
doi:10.1371/journal.pone.0122785.t007
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previous IHC-based reports [31,33], while our negative findings in the tongue are in contrast
with a study which detected abnormal PrP in this tissue [27]. Although the infectivity load in
Fig 3. Converting activity in the inocula from 1216B sheep analysed by vPMCA.Western blot analysis of the amplified products was carried out after the
3rd, 5th, 7th and 9th rounds, as indicated. The results obtained with the brain dilution curve are reported in left panels, those from visceral tissue inocula are in
right panels. Blots were probed with SAF84 primary antibody.
doi:10.1371/journal.pone.0122785.g003
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the kidney was low,>3 logs less than the brain, this finding is important as kidneys are not cur-
rently categorised as SRM and thus enter the human and pet food chain. Aside from this, the
findings in the present and previous studies [31,33,34] demonstrating that scrapie is present in
tissues which produce excretions/secretions such as kidneys and salivary glands, complement
studies in wild ruminants with CWD [35] and emphasize the potential role of urine and saliva
in the environmental spread of TSEs.
Regarding skeletal muscles, which are quantitatively the most important edible tissue in
terms of human exposure to prions, our findings corroborate previous data from VRQ/VRQ
sheep [36,37]. In agreement with Andreoletti and co-workers (2004), we found IHC-detectable
abnormal PrP exclusively in muscle spindles, which are innervated structures involved in pro-
prioception. Their number varies markedly among individual muscles, being least frequent in
the large muscles of the hind limb and much more frequent in muscles involved in fine motor
control, such as the intra-orbital muscles. Significantly, by analysing different type of muscles
we found that the frequency of muscle spindles roughly correlated with the probability of de-
tecting abnormal PrP and with the infectivity load, which has obvious implications for risk
modelling of infectivity entering the human food chain. However, even muscles with high spin-
dle content and that were positive by laboratory tests, such as the oculomotor muscles, har-
boured relatively low levels of infectivity per gram of tissue, i.e.*3 logs less than the brain and
*1–2 logs less than the lymph nodes. These results are in contrast with those obtained from a
single VRQ/VRQ sheep with natural scrapie [37], where skeletal muscles had infectious loads
similar to lymphoid tissues and only*1 log less than the brain. It is not certain if these dis-
crepancies are due to the sheep genotype, the scrapie strain involved or to technical aspects
such as tissue sampling, which indeed could result in significant bias given the uneven distribu-
tion of abnormal PrP observed in skeletal muscles.
Our negative findings in the liver are discrepant also from the results of a study with VRQ/
VRQ sheep [38]. In this latter study, 89% of sheep with scrapie were positive for abnormal PrP
in the liver by both ELISA and WB techniques similar to those used in the present study, sug-
gesting that technical aspects are not an explanation for the differences observed between
ARQ/ARQ and VRQ/VRQ sheep. Overall, these observations suggest that the prion strain and
the sheep genotype independently or together have a significant effect on the risk associated
with liver and muscle and indeed, in general, on the tissue distribution of the scrapie agent.
Beyond the general agreement between the different tests, some discrepancies in sensitivity
were found between the three WB methods, as well as between the two ELISAs. These where
evident where low titres of infectivity were present, for example in sciatic nerves, where centrif-
ugal concentration followed by WB and the Idexx antigen assay were more sensitive than the
other laboratory methodologies, or in kidneys, where BioRad TeSeE WB and ELISA were the
most sensitive tests. One possible explanation, supported by the similar observations compar-
ing the Bio-Rad TeSeE WB and ELISA that share the same tissue preparation method, could be
that different sample preparations might selectively favour the release of PrPSc from different
tissues. On the other hand, IHC results showed that PrPSc was present in specific locations
within the kidneys and muscles and a high proportion of the tissue was negative, therefore
gross sampling post-mortem may not have incorporated an area with PrPSc present. Further-
more, the amount of PrPSc within these tissues appears to be close to the detection limit of labo-
ratory tests and the final result may be reliant on the size of the starting sample. Overall, these
observations suggest that the focal and sparse accumulation of abnormal prion protein ob-
served in this study could have important implications for risk modellers, as it exemplifies how
difficult it could be to extrapolate mean data, such as ID50 per gram of tissue, from experimen-
tal data generated from a low number of tissue homogenates derived from relatively little
starting material.
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Importantly, in this study we looked for abnormal PrP and infectivity in the same tissue
samples that had been analysed by IHC. This approach offered a good perspective to compare
the results obtained, to derive meaningful correlations between abnormal PrP and scrapie in-
fectivity and to explain potential pitfalls of tissue homogenate-based approaches to infectivity
estimations. Overall, we observed a good correlation between the presence and relative quantity
of abnormal PrP and the presence and titre of infectivity in a given tissue. Indeed, by combin-
ing the results obtained with the different ELISA andWB techniques, we found that their pre-
dictive value was high, as only those tissues which were positive by one or more laboratory
method were positive by vole bioassay. This was further confirmed by WB detection of PrPSc
directly in the tissue homogenates used for bioassay in voles. Even more interesting, quantifica-
tion of PrPSc by WB or ELISA showed the same rank order of positivity as bioassay, with
lymph nodes (1-to-2 logs less than the brain)> sciatic nerves (2-to-3 logs less than the brain)
 oculomotor muscles and kidneys.
At first glance these conclusions would appear to contradict a previous study in which the
authors determined correlations among biochemical tests, bioassay and IHC [39]. However,
that study was concerned with brain regions and the distinct morphological types of abnormal
PrP observed therein. Significant heterogeneity is observed in the patterns of abnormal PrP
staining in the brain by IHC with regard to association with cell type, morphology and whether
the PrP is present as extracellular or intracellular particles. The regions evaluated in that study
were chosen to assess how well they correlate with the biochemical tests and the bioassay. In
the current study the brain samples are not distinguished based on these categories and with re-
gard to subtypes are likely to be more homogeneous than those in the previous study. Further-
more the cell types associated with abnormal PrP and the type of staining observed in visceral
tissues, within an individual tissue, are much less heterogeneous than that found among differ-
ent brain regions. Thus the findings from the two studies are not necessarily discordant. In ad-
dition, the use of a different model for bioassay (a transgenic mouse for ovine ARQ PrP) and
focus on BSE as the infectious agent may also account for differences in results.
In conclusion, our findings confirm and extend previous knowledge on the presence of in-
fectivity within the edible tissues of sheep with scrapie, and suggest that laboratory tests may be
exploited to extrapolate the infectivity titre in tissues derived from ARQ/ARQ sheep. Given the
sensitivity observed with PMCA, which was even more sensitive than bioassay, and the recent
advances made by several groups in scaling down protocols for quantitative PMCA [40,41],
this technique might be seen as a promising candidate to be optimised for a highly sensitive
quantitative assay.
Supporting Information
S1 Fig. Titration of infectivity in sheep brains by end point dilution in bank voles. Serial di-
lutions of brain homogenates from sheep 1216B (right panel) and sheep 1223B (left panel)
scrapie isolates were inoculated intracerebrally into bank voles. Symbols represent individual
survival times. The diseased voles were positive for brain PrPSc. Inoculated voles that were neg-
ative after 868 d.p.i. (right panel) or 862 d.p.i (left panel) are plotted in compressed form after
the x axes break point. Voles culled with intercurrent disease at>200 d.p.i. and negative by
WB are plotted as survivors. The mean survival time (days ± sd) and the number of diseased/
inoculated voles are indicated on the right of each chart. Both end-point titrations gave similar
results, in that the 10−1 and 10−2 dilutions gave 100% attack rate, the 10−3 and 10−4 dilutions
gave attack rates lower than 100%, while higher dilutions were unable to infect any inoculated
vole. The infectivity titres, calculated by the method of Spearmann and Karber, were 105.01 i.c.
ID50 U/g for the brain of sheep 1216B and 10
5.35 i.c. ID50 U/g for the brain of sheep 1223B.
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These results are in line with those previously published for brain tissues from sheep affected
by the same scrapie strain used in this project [13].
(TIF)
S2 Fig. Survival curves obtained from positive edible tissues of sheep 1216B and 1223B in
comparison with the respective brain dilutions. For sheep 1216B (top panel) the prescapular
LN gave a survival curve very similar to that of brain dilution 10−3, the sciatic nerve was inter-
mediate between dilutions 10−3 and 10−4, while oculomotor muscle and kidney were similar to
a brain dilution of 10−4 or less. For sheep 1223B (bottom panel) the prescapular LN gave a sur-
vival curve very similar to that of brain dilution 10−3, the sciatic nerve and oculomotor muscle
were intermediate between dilutions 10−3 and 10−4, while the kidney showed a survival rate
higher than brain dilution 10−4.
(TIF)
S3 Fig. Converting activity in unseeded negative controls analysed by vPMCA in parallel
with reactions seeded with sheep brain dilutions and edible tissues (shown in Fig. 3). The
western blot analysis of the amplified products carried out after the 9th vPMCA round shows
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